Quinupristin/dalfopristin: A novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens

This publication has 23 references indexed in Scilit:

• Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
  Journal of Antimicrobial Chemotherapy, 1999
• Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates
  The American Journal of Medicine, 1998
• State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
  Clinical Infectious Diseases, 1998
• Medium and supplement effects on the antimicrobial activity of quinupristin/dalfopristin tested by agar dilution and etest methods
  Diagnostic Microbiology and Infectious Disease, 1996
• Mechanism of Action of Streptogramins and Macrolides
  Drugs, 1996
• Streptogramins
  Drugs, 1996
• Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus
  Antimicrobial Agents and Chemotherapy, 1995
• The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC
  Journal of Antimicrobial Chemotherapy, 1994
• Post-antibiotic effect of the new streptogramin RP 59500
  European Journal of Clinical Microbiology & Infectious Diseases, 1992
• In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci
  Antimicrobial Agents and Chemotherapy, 1991